Iptacopan Hydrochloride Patent Expiration
Iptacopan Hydrochloride was first introduced by Novartis Pharmaceuticals Corp
Iptacopan Hydrochloride Patents
Given below is the list of patents protecting Iptacopan Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Fabhalta | US11603363 | Crystalline form of LNP023 | May 25, 2041 | Novartis |
| Fabhalta | US11951101 | Methods of using factor B inhibitors | Jul 15, 2041 | Novartis |
| Fabhalta | US9682968 | Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof | Jul 14, 2034 | Novartis |